Last 12 months
Inside the activity.
6 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 3 | 5 |
| Feb 2026 | 0 | 10 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2023 Filed Jul 26, 2023 22:13 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Disposition to issuerStock Options (Right to buy) · Derivative | 71,524 | Not disclosed Strike: $20.67 | Not disclosed |
DisclosureSEC source: 0000905148-23-000510 · form4.xml · derivative · entry 4 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,524 shares Expires 2031-02-22 F3 · kind: On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023. F4 · kind: The Reporting Person elected to participate in the Tender Offer and received 27,138 Replacement Options with an exercise price of $1.20 per share in exchange for 132,963 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled. F3 · price: On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023. F4 · price: The Reporting Person elected to participate in the Tender Offer and received 27,138 Replacement Options with an exercise price of $1.20 per share in exchange for 132,963 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled. F2 · derivative.exercise_date: This option was fully vested as of the grant date. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 22:13 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Disposition to issuerStock Options (Right to buy) · Derivative | 61,439 | Not disclosed Strike: $20.67 | Not disclosed |
DisclosureSEC source: 0000905148-23-000510 · form4.xml · derivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,439 shares Expires 2031-02-22 F3 · kind: On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023. F4 · kind: The Reporting Person elected to participate in the Tender Offer and received 27,138 Replacement Options with an exercise price of $1.20 per share in exchange for 132,963 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled. F3 · price: On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023. F4 · price: The Reporting Person elected to participate in the Tender Offer and received 27,138 Replacement Options with an exercise price of $1.20 per share in exchange for 132,963 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled. F1 · derivative.exercise_date: This option was scheduled to vest in a series of 60 successive, equal monthly installments measured from February 23, 2021. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 19:00 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 14,792 | $1.35 | $20,006.18 |
DisclosureSEC source: 0001140361-23-027746 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,589,853 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 19:00 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 11,849 | $1.36 | $16,150.19 |
DisclosureSEC source: 0001140361-23-027746 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,575,061 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 25, 2023 Filed May 30, 2023 19:03 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 52,508 | $1.36 | $71,279.61 |
DisclosureSEC source: 0001140361-23-027206 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,563,212 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 24, 2023 Filed May 26, 2023 19:00 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 35,308 | $1.25 | $43,979.64 |
DisclosureSEC source: 0001140361-23-026925 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,510,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:21 UTC |
SCHULER JACK WDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 28,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026715 · form4.xml · derivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,873 Underlying: Common Stock · 28,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 19:00 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 56,782 | $1.15 | $65,066.49 |
DisclosureSEC source: 0001140361-23-026580 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,475,396 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1125 to $1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:22 UTC |
PATIENCE JOHNDirector · 10% owner · Chairman
|
GrantRestricted Stock Units · Derivative | 28,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026720 · form4.xml · derivative · entry 1 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,873 Underlying: Common Stock · 28,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 18:21 UTC |
MASSARANY HANYDirector
|
GrantRestricted Stock Units · Derivative | 37,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026714 · form4.xml · derivative · entry 1 MASSARANY HANY · CIK 0001134554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,535 Underlying: Common Stock · 37,535 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 18:21 UTC |
Watts Charles MDirector
|
GrantRestricted Stock Units · Derivative | 28,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026716 · form4.xml · derivative · entry 1 Watts Charles M · CIK 0001723751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,873 Underlying: Common Stock · 28,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:22 UTC |
Franchi Jean M.Director
|
GrantRestricted Stock Units · Derivative | 40,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026721 · form4.xml · derivative · entry 1 Franchi Jean M. · CIK 0001653053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,422 Underlying: Common Stock · 40,422 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:22 UTC |
Strobeck MatthewDirector
|
GrantRestricted Stock Units · Derivative | 34,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026719 · form4.xml · derivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,647 Underlying: Common Stock · 34,647 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:21 UTC |
Kayyem Jon FaizDirector
|
GrantRestricted Stock Units · Derivative | 28,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026718 · form4.xml · derivative · entry 1 Kayyem Jon Faiz · CIK 0001366268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,873 Underlying: Common Stock · 28,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 23, 2023 Filed May 25, 2023 22:21 UTC |
Kennedy Lawrence T. JrDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 28,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-026717 · form4.xml · derivative · entry 1 Kennedy Lawrence T. Jr · CIK 0001830773 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,873 Underlying: Common Stock · 28,873 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document |
| May 22, 2023 Filed May 24, 2023 19:47 UTC |
SCHULER JACK WDirector · 10% owner
|
PurchaseCommon Stock | 29,425 | $1.11 | $32,529.34 |
DisclosureSEC source: 0001140361-23-026395 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,418,614 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.085 to $1.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:16 UTC |
Hutton ScottDirector · President & CEO
|
SaleCommon Stock | 3,848 | $1.58 | $6,064.83 |
DisclosureSEC source: 0001140361-23-023966 · form4.xml · nonDerivative · entry 3 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,722 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 11, 2023 00:16 UTC |
Siurek Ryan HChief Accounting Officer
|
SaleCommon Stock | 564 | $1.58 | $888.92 |
DisclosureSEC source: 0001140361-23-023967 · form4.xml · nonDerivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,268 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 11, 2023 00:16 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
SaleCommon Stock | 973 | $1.58 | $1,533.55 |
DisclosureSEC source: 0001140361-23-023969 · form4.xml · nonDerivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,365 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 11, 2023 00:16 UTC |
O'Kane KieranChief Commercial Officer
|
SaleCommon Stock | 474 | $1.58 | $747.07 |
DisclosureSEC source: 0001140361-23-023968 · form4.xml · nonDerivative · entry 3 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,757 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 11, 2023 00:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
SaleCommon Stock | 426 | $1.58 | $671.42 |
DisclosureSEC source: 0001140361-23-023965 · form4.xml · nonDerivative · entry 3 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,460 F2 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:16 UTC |
Hutton ScottDirector · President & CEO
|
SaleCommon Stock | 9,934 | $1.57 | $15,560.62 |
DisclosureSEC source: 0001140361-23-023966 · form4.xml · nonDerivative · entry 2 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,570 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:16 UTC |
Siurek Ryan HChief Accounting Officer
|
SaleCommon Stock | 1,456 | $1.57 | $2,280.68 |
DisclosureSEC source: 0001140361-23-023967 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,832 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:16 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
SaleCommon Stock | 2,512 | $1.57 | $3,934.80 |
DisclosureSEC source: 0001140361-23-023969 · form4.xml · nonDerivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,338 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:16 UTC |
O'Kane KieranChief Commercial Officer
|
SaleCommon Stock | 1,223 | $1.57 | $1,915.71 |
DisclosureSEC source: 0001140361-23-023968 · form4.xml · nonDerivative · entry 2 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,231 F3 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 11, 2023 00:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
SaleCommon Stock | 1,101 | $1.57 | $1,724.61 |
DisclosureSEC source: 0001140361-23-023965 · form4.xml · nonDerivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,886 F2 · kind: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:16 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 32,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023966 · form4.xml · derivative · entry 5 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,565 Underlying: Common Stock · 32,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F7 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:16 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023966 · form4.xml · derivative · entry 4 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,332 Underlying: Common Stock · 12,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:16 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 44,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-023966 · form4.xml · nonDerivative · entry 1 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023967 · form4.xml · derivative · entry 5 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,557 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F7 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023967 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,193 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-023967 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023969 · form4.xml · derivative · entry 5 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,418 Underlying: Common Stock · 8,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F7 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023969 · form4.xml · derivative · entry 4 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,724 Underlying: Common Stock · 3,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionCommon Stock | 11,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-023969 · form4.xml · nonDerivative · entry 1 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023968 · form4.xml · derivative · entry 5 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,972 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F7 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023968 · form4.xml · derivative · entry 4 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,384 Underlying: Common Stock · 1,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,461 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-023968 · form4.xml · nonDerivative · entry 1 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023965 · form4.xml · derivative · entry 5 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 Underlying: Common Stock · 3,676 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023965 · form4.xml · derivative · entry 4 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,161 Underlying: Common Stock · 1,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F5 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 08, 2023 Filed May 11, 2023 00:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionCommon Stock | 5,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-023965 · form4.xml · nonDerivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:39 UTC |
MASSARANY HANYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 145,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-016265 · form4.xml · derivative · entry 2 MASSARANY HANY · CIK 0001134554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,707 Underlying: Common Stock · 145,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: These RSUs vested in full on March 31, 2023. F2 · derivative.expiration_date: These RSUs vested in full on March 31, 2023. F3 · balance_after: This amount includes 6,707 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:39 UTC |
MASSARANY HANYDirector
|
Exercise / conversionCommon Stock | 145,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-016265 · form4.xml · nonDerivative · entry 1 MASSARANY HANY · CIK 0001134554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:33 UTC |
Watts Charles MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 150,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-016257 · form4.xml · derivative · entry 2 Watts Charles M · CIK 0001723751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: These RSUs vested in full on March 31, 2023. F2 · derivative.expiration_date: These RSUs vested in full on March 31, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:33 UTC |
Watts Charles MDirector
|
Exercise / conversionCommon Stock | 150,711 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-016257 · form4.xml · nonDerivative · entry 1 Watts Charles M · CIK 0001723751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:36 UTC |
Kayyem Jon FaizDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 145,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-016261 · form4.xml · derivative · entry 3 Kayyem Jon Faiz · CIK 0001366268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,878 Underlying: Common Stock · 145,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: These RSUs vested in full on March 31, 2023. F3 · derivative.expiration_date: These RSUs vested in full on March 31, 2023. F4 · balance_after: This amount includes 4,878 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:36 UTC |
Kayyem Jon FaizDirector
|
Exercise / conversionCommon Stock | 145,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-016261 · form4.xml · nonDerivative · entry 1 Kayyem Jon Faiz · CIK 0001366268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:16 UTC |
Hutton ScottDirector · President & CEO
|
GrantStock Options (Right to buy) · Derivative | 435,668 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-23-010026 · form4.xml · derivative · entry 1 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,668 Underlying: Common Stock · 435,668 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:16 UTC |
Siurek Ryan HChief Accounting Officer
|
GrantStock Options (Right to buy) · Derivative | 114,204 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-23-010028 · form4.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,204 Underlying: Common Stock · 114,204 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:16 UTC |
Pestano Gary AnthonyChief Development Officer
|
GrantStock Options (Right to buy) · Derivative | 8,614 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-23-010027 · form4.xml · derivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,614 Underlying: Common Stock · 8,614 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.